The ClearSight system quickly connects to the patient by wrapping an inflatable cuff around the finger.
Using the cuff on the outside of the finger that is connected to the Edwards EV1000 clinical platform, the ClearSight system uses the company’s monitoring technologies that are used in hospitals around the world.
The ClearSight system incorporates a finger cuff and software elements that have been used for the noninvasive monitoring of the blood pressure of astronauts in space.
Edwards Lifesciences’ advanced noninvasive monitoring system automatically provides up-to-the-minute information without inserting anything into the body.
The ClearSight system provides an opportunity to extend the benefits of hemodynamic optimization, or proper fluid administration and balance within a patient’s organs and tissues, to a broader patient population that could benefit from close monitoring, but may not receive it without a noninvasive option.
Edwards Lifesciences critical care and vascular corporate vice president Carlyn Solomon said that the ClearSight system is the most advanced noninvasive monitor of its kind.
"This important development in the field of critical care medicine builds on Edwards’ 40 years of experience in providing clinicians with tools to make more informed decisions that can advance patient care by helping to reduce complications, shorten hospital stays and lower associated costs," Solomon added.
The ClearSight advanced noninvasive monitoring system is also available in CE Mark countries.
Image: The ClearSight system extends valuable dynamic and flow-based HD management to a broader patient population. Photo: Courtesy of PRNewswire/ Edwards Lifesciences Corporation
